FGF19 and metabolic dysfunction-associated steatotic liver disease: Therefore, the objective of this study was to investigate whether the impairment of FXR-FGF19 signaling in diet-induced NAFLD pigs is associated with the upregulation of CYP8B1 expression in the liver and an increased enterohepatic CA to CDCA ratio.